<- Go Home
Cambrex Corporation
Cambrex Corporation operates as a life sciences company that provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as finished dosage forms. The company serves generic drug companies and companies that discover and commercialize small-molecule human therapeutics. The company sells its products directly as well as through independent agents. The company was founded in 1981 and is based in East Rutherford, New Jersey with additional locations across the globe.
Market Cap
$2.0B
Volume
437.3K
Cash and Equivalents
$80.8M
EBITDA
$160.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$215.8M
Profit Margin
34.91%
52 Week High
$60.29
52 Week Low
$33.80
Dividend
N/A
Price / Book Value
2.99
Price / Earnings
56.66
Price / Tangible Book Value
91.74
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$102.5M
Return on Equity
5.37%
Return on Assets
4.65
Cash and Short Term Investments
$80.8M
Debt
$538.0M
Equity
$675.9M
Revenue
$618.1M
Unlevered FCF
$114.3M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium